Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 10.13 MB)

  Published:

  11 January 2023

• Final appraisal determination committee papers (PDF 2.43 MB)

  Published:

  11 January 2023